retatrutide ganglia hemorrhage GLP‐1 Receptor Agonists in Metabolic Dysfunction‐Associated Steatotic Liver Disease: Bridging Hepatic and Cardiovascular Outcomes - Amorim Moreira Alves - 2026 - Chronic Diseases and Translational Medicine Ophthalmologic symptoms as the first

Our study addresses an important and practical question: whether GLP-1 receptor agonists appear safe in this population and whether their use is associated with meaningful clinical outcomes such as steroid dependence and hospitalization. The researchers used the TriNetX research network to identify adults with Crohns disease and overweight or obesity who either started a GLP-1 receptor agonist or had no exposure

This includes costs for treatment, hospital stays, medication, and any necessary medical procedures

T.MasciaE.et al (2018)

Why Choose EverGlo Aesthetic Clinic, Velachery

Hold if GI symptoms are affecting sleep or work performance